XLONVCT
Market cap1.17bUSD
Dec 24, Last price
1,074.00GBP
1D
-0.19%
1Q
14.13%
Jan 2017
-44.38%
Name
Victrex PLC
Chart & Performance
Profile
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. It serves automotive, aerospace, energy and industrial, manufacturing and engineering, electronics, and medical markets. Victrex plc was founded in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | 2016‑09 | 2015‑09 | |
Income | ||||||||||
Revenues | 296,200 -3.52% | 307,000 -9.97% | 341,000 11.33% | |||||||
Cost of revenue | 250,400 | 233,800 | 241,600 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 45,800 | 73,200 | 99,400 | |||||||
NOPBT Margin | 15.46% | 23.84% | 29.15% | |||||||
Operating Taxes | 7,600 | 11,500 | 12,200 | |||||||
Tax Rate | 16.59% | 15.71% | 12.27% | |||||||
NOPAT | 38,200 | 61,700 | 87,200 | |||||||
Net income | 17,200 -72.12% | 61,700 -19.03% | 76,200 4.10% | |||||||
Dividends | (51,800) | (51,800) | (95,200) | |||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 200 | 400 | 29,000 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 9,200 | 6,800 | 2,700 | |||||||
Long-term debt | 51,200 | 53,900 | 29,400 | |||||||
Deferred revenue | 1 | 7,800 | ||||||||
Other long-term liabilities | 2,500 | 2,500 | 2,700 | |||||||
Net debt | 31,100 | 4,900 | (57,200) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 84,000 | 40,800 | 80,000 | |||||||
CAPEX | (32,600) | (38,500) | (45,500) | |||||||
Cash from investing activities | (35,400) | (32,300) | (16,200) | |||||||
Cash from financing activities | (51,900) | (32,800) | (82,400) | |||||||
FCF | 48,800 | 26,200 | (900) | |||||||
Balance | ||||||||||
Cash | 29,300 | 33,500 | 68,800 | |||||||
Long term investments | 22,300 | 20,500 | ||||||||
Excess cash | 14,490 | 40,450 | 72,250 | |||||||
Stockholders' equity | 399,500 | 439,100 | 429,100 | |||||||
Invested Capital | 500,010 | 513,250 | 450,850 | |||||||
ROIC | 7.54% | 12.80% | 20.37% | |||||||
ROCE | 8.25% | 12.46% | 17.83% | |||||||
EV | ||||||||||
Common stock shares outstanding | 87,992 | 87,496 | 87,239 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 69,000 | 94,700 | 121,000 | |||||||
EV/EBITDA | ||||||||||
Interest | 1,900 | 700 | 300 | |||||||
Interest/NOPBT | 4.15% | 0.96% | 0.30% |